U.S. Markets closed

Nektar Therapeutics Stock Poised for Significant Move

Nektar Therapeutics Stock Poised for Significant Move

Shares of the U.S.-based pharmaceutical company could be set for a 45% swing as they break out from a classic wedge pattern.